The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis

Explore this paper's citation graph

Summary

Clinical utility of the intraperitoneal chemotherapy component of HIPEC is supported as it inhibited tumor growth independent of cytoreduction or hyperthermia, demonstrated improved peritoneal tissue concentration and was associated with increased survival.

Type
article
Published
2013-05-15
Cited by
14
References
23
Access
Open access

Keywords

Medicine, Carcinosis, Mitomycin C, Intraperitoneal chemotherapy, Hyperthermic intraperitoneal chemotherapy

References

Cited by

Related papers